Summary
The pathogenic potential of autoimmune T cell responses to nonmyelin autoantigens was investigated in the Lewis rat using the astrocyte-derived calcium binding protein $100/3, as a model nonmyelin autoantigen. The Lewis rat mounts a vigorous RT1B 1 (major histocompatibility complex class II) restricted autoimmune response to an immunodominant $100/3 epitope (amino acid residues 76-91). The adoptive transfer of S100/3-specific T cell lines induced a severe inflammatory response in the nervous system, but only minimal neurological dysfunction in naive syngeneic recipients. The inability of S100j3-specific T cell transfer to induce severe disease was associated with a decreased recruitment of ED1 § macrophages into the central nervous system (CNS) in comparison with that seen in severe experimental autoimmune encephalomyelitis (EAE) induced by the adoptive transfer of myelin basic protein (MBP)-specific T line cells. Moreover, unlike encephalitogenic MBP-specific T cell lines, S100/3-specific T cell lines exhibited no cytotoxic activity in vitro. Histopathological analysis also revealed striking differences in the distribution of inflammatory lesions in MBP-and S100/3-specific T cell-mediated disease. In contrast to the MBP paradigm, S100/3-specific T cell transfer induces intense inflammation not only in the spinal cord, but throughout the entire CNS and also in the uvea and retina of the eye. In view of the distribution of lesions throughout the grey and white matter of the CNS we propose to term this new model experimental autoimmune panencephalomyelitis (EAP) to differentiate it from EAE. These experiments demonstrate for the first time that nonmyelin CNS autoantigens can initiate a pathogenic autoimmune T cell response, although the nature of the target autoantigen profoundly influences the clinical and histopathological characteristics of the resulting autoimmune disease. This is not simply a consequence of the distribution of the autoantigen, as both MBP and $100/3 are coexpressed in many areas of the CNS, but reflects differences in the capacity of different regions of the CNS to process and present specific autoantigens. This new model of T cell-mediated autoimmune CNS disease exhibits a number of similarities to multiple sclerosis (MS), such as its mild clinical course and the involvement of areas of the brain and eye, which are absent in myelin-mediated models of EAE. Nonmyelin autoantigens may therefore play an unexpectedly important role in the immunopathogenesis of inflammatory diseases of the CNS.
T wo basic tenets in cellular immunology were radically revised during the past decade as a direct consequence of studies of experimental autoimmune encephalomyelitis (EAE) 1. First, the concept of "immunoprivilege" with re-1 Abbreviations used in this paper: BBB, blood-brain barrier; CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; EAP, experimental autoimmune panencephalitis; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; PPD, purified protein derivative. spect to the central nervous system (CNS) was reappraised after the demonstration that not only can activated T lymphocytes migrate through the endothelial blood-brain barrier (BBB) regardless of their antigen specificity (1, 2) ; but also that the CNS contains numerous cellular elements (astrocytes, microglia, cerebral endothelial cells) that can function as APCs (3) (4) (5) . Second, the isolation of encephalitogenic T cell lines from both myelin-primed (6) and naive rats (7) demonstrated that potentially autoaggressive T cell clones are not necessarily silenced by either deletion or anergy, but are normal components of the healthy immune repertoire (8, 9) .
However, these results are all derived from studies in which EAE is mediated by an autoaggressive T cell response against a single myelin antigen, the myelin basic protein (MBP), which until very recently appeared to be the predominant, if not the only, encephalitogenic protein present in the CNS. Analysis of the encephalitogenic, MBP-specific T cell response revealed that it exhibited several unusual properties. In at least two species, the Lewis rat and mice with the H-2 u haplotype (PL/J and B10.PL strains), the primary MBP-specific T cell response is directed against single, strongly immunodominant epitopes, the identity of which is species and strain dependent. Furthermore, encephalitogenic T cells specific for these immunodominant epitopes use a highly restricted repertoire of TCK genes, generally TCR V~8.2 in combination with V~2/V~4 elements (10-13). The potential therapeutic relevance of these observations was rapidly demonstrated in EAE (14) (15) (16) (17) (18) ; however, the molecular characteristics responsible for the encephalitogenicity of the MBP-specific T cell response have still to be elucidated. In particular, it has to be demonstrated whether EAE mediated by myelin-specific T cells provides a general paradigm to study inflammatory responses in the CNS, or is a special case of limited usefulness.
To approach this problem and identify the structural/functional characteristics of CNS proteins necessary to induce EAE, we elected to study the encephalitogenic potential of nonmyelin CNS proteins that differ from MBP with respect to their site of synthesis and physicochemical characteristics. One of these proteins was $100/3, a calcium binding protein that was first isolated from the CNS. S100B is a small, highly soluble, acidic protein consisting of 91 amino acids (19, 20) . Like MBP, S100B is a major component of the nervous system, accounting for •0.4% of the total soluble protein in the CNS (21), but unlike MBP which is only present in oligodendrocytes and myelin, expression of $100/3 in the CNS is restricted to astrocytes. Elsewhere, $100~ is also expressed by Schwann cells in the peripheral nervous system and Mtiller cells in the retina (22, 23) . Astrocytes also secrete a biologically active form of SIOOB and the protein can be detected in the cerebrospinal fluid (24, 25) .
To provide a direct comparison with the encephalitogenic MBP-specific T cell response a panel of S100/3-specific T cell lines was generated from both bulk, and limiting dilution cultures of lymph node cells obtained from S100B-primed animals. These T cell lines were then analyzed in vitro with respect to their epitope specificity, phenotype, TCR V0 gene usage, cytokine production, and cytotoxicity, and in vivo after adoptive transfer into naive syngeneic recipients to determine Bovine $100~ protein differs from rat S100B at residues 7 (Met/Val), 62 (Glu/Ser), 78 (Ser/Ala), and 80 (Val/lle).
their pathogenic potential. S100B-specific, class II MHC-restricted, CD4 § Thl T line cells were found to mediate an intense inflammatory response throughout the CNS that differs dramatically from MBP-mediated EAE with respect to lesion distribution, structure and cellular composition. Additionally, S100B-specific T cells induce inflammatory changes in both the uvea and retina of the eye, a pathology reported to occur in a subgroup of patients with multiple sclerosis (MS) (26) . These observations demonstrate that MBP and other myelin proteins are not the only CNS autoantigens able to induce extensive autoimmune-mediated encephalomyelitis/panencephalomyelitis in mammals. A potential role for autoimmune responses to nonmyelin autoantigens will now have to be considered the pathogenesis of inflammatory diseases of the CNS, in particular MS.
ceeding rat T cell receptor-specific mAbs were used: R73 (constant region of TCR-ce//3 [27] ); R78 (TCR Vo 8.2); B73 (TCR V08.5); and G101 (TCR Val0) (28) and HIS42 (TCR Vol6). Rat macrophages and microglia were differentiated using the mAbs TRPM3 (29) , ED1, ED2, ED3 (30) , and MUC102 (31) . Rabbit anti-S100~ and anti-GFAP antisera were purchased from Sigma Chemical Co. W3/13, W3/25, OXS, OX39, and MUC102 were purified in our laboratory from the culture supernatants of the appropriate hybridoma cell lines; ED mAbs, OX22, OX42, and HIS42 were purchased from Serotec (Oxford, UK) and TR.PM3 from Dianova (Hamburg, Germany).
Antigen-specific T Cell Lines. Lewis Two different protocols were used to establish antigen specific T cell lines. 10 d after immunization single cell suspensions were prepared from the draining lymph nodes. The primed cells were either cultured at a concentration of 107 cells/ml to establish bulk T cell lines (LS) (6), or alternatively serially diluted to provide a large number of pauciclonal T cell lines (prefixed; S1 [32] ). In the latter case, lymph node cell suspensions were cultured in 96-well round-bottom microtiter plates at cell numbers ranging from 2 x 105 to 100 cells/well. The wells were supplemented with antigen and irradiated (4,000 rad) syngeneic thymus cells to give a final cell number of 2 x 10Vwell. After 3 d, the media was removed and the remaining T cells expanded for a further 7-10 d in media supplemented with IL-2. The T cells were then restimulated with antigen in the presence of 2 x l0 s irradiated (4,000 rad) syngeneic thymus cells/well. After visual inspection of the cultures, those positive for growth were expanded in the presence of IL-2 and antigen-specific S1 T cell lines selected as described for the bulk culture-derived LS cell lines. The LS and S1 T cell lines were then subsequently propagated as described previously (6, 33) .
Proliferation and L ymphokine Assays. Lymph node cells (2 x 10S/well), or 2 x 104 T line cells plus 0.9 x 106 irradiated (4,000 rad) syngeneic thymocytes were cultured in 0.2 ml medium in 96-well round-bottomed microtiter plates in the presence or absence of the appropriate antigens. After 56 h, 1 #Ci/well [3H]thymidine was added and the cells were harvested 16 h later. The mean cpm were determined for triplicate cultures using a solid phase gas scintillation counter (Matrix 96 Direct Beta Counter; Packard, Frankfurt, Germany). It should be noted that the counts obtained by this method are approximately five times lower than with methods using scintillation fluid.
The ability of either syngeneic astrocytes or the mouse L cell line, RT3.3, which is transfected with functional RTIB 1 to act as APCs was determined using irradiated cultures (5,000 tad) seeded into flat bottomed 96-well plates at a density of 2 x 104 cells/weU. T line cells (2 x 104/well) were added to give a total volume of 0.2 ml media in the presence or absence of antigen. T cell proliferation was determined at the end of 3 d culture as described above. The cell line RT3.3 was established using the mulcos system (34) (a kind gift from Dr. I. Saito, National Institutes of Health, Toyko, Japan). Briefly, cDNA clones pLRB118 (35) and pLR~x6 (36) were inserted into EcoRI and HindlII sites respectively of the cassette plasmid pmoRH, excised by Sill digestion and ligated with the Sfil linearized cosmid vector dCHD2L (34) . MHC class II and invariant chain negative rat-2 cells (106) were transfected with 5/ig of cosmid DNA employing the DOTAP procedure (Boehringer Mannheim, Mannheim, Germany) following the supplier's instructions. Transfectants were selected using Hygromycin B at 200/xg/ml added 48 h after transfection.
Cytokine assays were performed on the culture supernatants of the various T cell lines as described previously (37) after 48 h of antigen-specific restimulation. IFN-3' levels were measured using a rat IFN-3' ELISA kit (Holland Biotechnologies, Leiden, The Netherlands). The IL-2-dependent CTLL cell line was used to assay IL-2 activity using mouse rlL-2 as a standard. II--6 activity was determined using the IL-6--dependent 7TD1 hybridoma cell line. TCRoe//3 activity was assayed using TNF-oe//3--sensitive LM cells and a polyclonal TNF-ot-specific goat antimurine antibody (Genzyme Corp., Cambridge, MA). The 7TD1 and LM ceils were generously provided by Dr. K. Frei (Universit~itespital Zurich, Switzerland).
Cytofluorographic Analysis. The surface phenotype of the T cell lines was investigated by indirect immunofluorescence staining. 2 x 10 s viable cells were washed with PBS containing 0.2% BSA and 10 mM NaN3 and incubated with the primary mAb for 1 h on ice. The cells were washed to remove the primary antibody and stained with fluorescein conjugated goat anti-mouse IgG (Dianova, Hamburg, Germany) for 1 h on ice. Cells were then washed and immediately analyzed using a FACScan | (Becton Dickinson, Heidelberg, Germany). A live gate was obtained by incubating the cells in PBS containing propidium iodide.
Induction of EAE. Lewis rats were injected into the tail vein
with varying numbers of T cell blasts harvested after 72 h of antigen driven restimulation. Animals were cared for in accordance with German federal regulations and weighed and examined for clinical signs of EAE on a daily basis. EAE severity was scored as: 0, no disease; 0.5, partial loss of tail tonus; 1, complete tail atony; 2, hind limb paraparesis; 3, hind limb paralysis; 4, moribund; 5, death. Demyelination was induced 5 d after the injection ofT cells by the intravenous injection of 4 mg of the mouse mAb 8-18C5 specific for the myelin oligodendrocyte glycoprotein (MOG) (38) .
Histology. Rats were perfused through the heart with 4% paraformaldehyde in PBS and tissue postfixed in the same fixative for 3 h at 4~ Alternatively, tissues were removed and immediately snap frozen. Multiple sections were stained with hematoxylin-eosin and Luxol fast blue. Immunocytochemistry was performed on both paraffin embedded and frozen sections as described previously (39) .
The frequency of inflammatory infiltrates in the cortex, periventricular white matter, diencephalon, mesencephalon, cerebellum, medulla oblongata, and spinal cord was determined by counting the number of perivenous inflammatory cuffs in multiple hematoxylin-eosin-stained sections in standardized regions of a total area of 375 mmVanimal. The results are expressed as the number of inflammatory infiltrates/mm 2. The total number of T cells and macrophages was determined in sections immunostained with the appropriate antibodies using a 100-point morphometric lattice placed in the microscope's ocular (ocular x 10, objective x 100). The total area quantitated was 0.6 mm 2 in the spinal cord and 0.2 mm 2 in the sciatic nerves and spinal roots and the results are presented as the number of cells/mm 2 of tissue area.
Astrocyte Culture Astrocytes were prepared from newborn lewis rat cerebra. The meninges were removed and a single cell suspension prepared by trypsinization and seeded into plastic culture flasks (4) . The nonadherent cells were removed after 4 h and cultured in 5% CO2 at 37~ The medium was first replaced after 24 h and subsequently every 3-4 d. After 10 d the primary cultures were shaken for 3-5 h to remove microglial cells. The remaining adherent astrocytes were removed by trypsinization and transferred to flasks at a density of 3 x 104/cm 2. After a further 2-3 wk in culture, the cells were again harvested by trypsinization before use Antigen specific T line cells (2 x 104/well) were cultured in triplicate with irradiated (4,000 rad) syngeneic tbymocytes (0.9 x 106/we11) in the presence or absence of either the synthetic rat $1003 peptides (Table 1) , bovine $1003, PPD (final concentrations 10 #g/ml), or Con A (2.5/~g/ml) for 3 d. Cultures were pulsed with [3H]TdR for the last 16 h of the 72-h culture and the incorporation of isotope determined as described. The results are presented as the mean cpm obtained, standard deviations were no more than 16%. In addition to the response to peptide D3 the following responses to peptides C6 (LS1, 305 cpm; LS2, 410 cpm; $1-F4, 264 cpm) and A5 ($1-E2, 324 cpm) were observed. Astrocyte Cytotoxicity Assays. Astrocytes harvested by trypsinisation were cultured in 96-well flat-bottom plates in complete basal medium (Eagles) (BME) (104/well) in the presence or absence of 100 U/ml of rat rlFN-7 (Holland Biotechnologies) for 48 h before use in either cytotoxicity or proliferation assays. Cytotoxicity was determined by 51Cr release (40) . The cells were labeled with 51Cr (1/~Ci/10 4 cells) for 2 h at 37~ Excess 51Cr was removed by washing the cells three times, followed by incubation at 37~ for 5 h and a second round of washing. Freshly harvested T cell blasts were added to the labeled astrocytes in complete DME to give different E/T ratios in the presence or absence of the antigen (10/~g/ml). Radioactivity was measured in triplicate using a gamma counter (Cobra Auto-gamma 5003; Packard) after a 12-h incubation. Maximal lysis was determined after incubation of the astrocytes with 2.5% Triton X-100.
Results
Characterization of SIOOfl-specific T Cell Lines. Lewis rats immunized with bovine S100fl mounted a vigorous T cell response to this antigen and of a total of 61 S100fl-specific T cell lines generated during this study, 21 were investigated in more detail; 2 T cell lines derived from bulk cultures (LS1 and LS2); and a further 19 S100fl-specific $1 T cell lines derived from microcultures. After three restimulation cycles the T cell lines were specific for bovine S100fl protein and exhibited no residual response to PPD ( Table 2) .
The eight S100fl-specific T cell lines analyzed by FACS | all exhibited the classical W3/13 +, OXS-, CD25 + and TCR-odfl + phenotype of CD4 + rat T cell lines. However they are clearly differentiated from encephalitogenic CD4 § MBP-specific rat T cell lines and clones by their TCR Va gene usage (Table 3) . Unlike the MBP-specific T cell lines, S100fl-specific T cell lines do not preferentially use TCR. Va8.2.
The spectrum of cytokines secreted by representative T cell lines specific for either S100fl (LS1, S1-D2, SP-D3) or MBP (Z85 [37] CP1 [34] , 34LMR) was analyzed during the first 48 h of an antigen-specific restimulation. All T cell lines secreted IFN-% IL-6, and TNF-o~ into the medium and IL-2 was detected at low levels in the supernatants with the exception of Z85 (Table 4 ). The production of IFN-3r indicates that these cell lines are of the Thl subtype. The MHC restriction of the Lewis rat T cell response to bovine S100fl was established using the T cell line $1-D2. The anti-rat I-A mAb OX6 (125/~g/ml) reduced the proliferative response of this T cell line to S100fl by 70%, whereas the same concentration of mAb reduced the proliferative response of a control MBP-specific T cell line, C1-C9, by 97%. The mAbs OX17 and OX18 had no significant effect on the proliferative response of either T cell line. These results were confirmed using the transfected rat-2 mouse L cell line RT3.3, which expresses both the c~ and fl chains of Lewis rat I-A. This mouse fibroblast call line was capable of acting as an APC in vitro inducing an antigen-specific proliferative response in both T cell lines tested (Table 5) .
Identification of the Target Epitopes and V• TCR Usag~ A
panel of sixteen overlapping synthetic rat S100fl peptides (Table  1 ) was used to identify T cell epitopes recognized by the S100fl-specific T cell lines. The T cell lines LS1 and LS2 both recognized an immunodominant epitope common to both rat and bovine S100fl located within the COOH-terminal sequence of the protein, amino acid 76-91, peptide D3 (Fig. 1) . Analysis of the $1 T cell lines sdected from serial dilutions of the original lymph node cell preparations confirmed that the rat S100fl sequence 76-91 was a dominant epitope with respect to the T cell response to bovine S100fl (Table 2) . However, although all $1 T cell lines proliferated strongly in response to native bovine S100fl, the proliferative response to this epitope was significantly lower than that seen in the bulkderived T cell lines LS1 and LS2. Proliferation in response to peptide D3 ranged from 20 to 55% of the response to bovine S100fl for eight of the $1 T cell lines analyzed, while the remaining T cell lines responded poorly to this rat epitope. In the case of the T cell hnes such as $1-G8 and $1-G9 The MHC restriction of the T cell lines $1-D2 (S100B-specific) and C1-C9 (MBP-specific) was determined using the mAbs OX6, OX17, and OX18. Confirmation that these responses were I-A restricted was obtained using the transfected mouse L cell line, KT3.3, that expresses Lewis rat KT1B 1. Expression was confirmed by both FACS | analysis and biosyntheic labelling. The data are presented as the mean cpm of triplicate cultures _+ SD.
The percent inhibition obtained in the presence of the mAb OX6 is given in brackets.
there was no response to any of the peptides tested indicating that they recognize bovine S100/~-specific epitopes ( Table 2 ). The T cell line, SP-D3, established from Lewis rats immunized with the peptide D3 (amino acid 76-91), as anticipated, proliferated vigorously in response to both the immunizing peptide and native bovine $100/~ ( Table 2 ). All subsequent studies were performed using the T cell lines LS1, LS2, $1-D2, $1-C7, $1-G7, $1-G9, and SP-D3, which exhibit differing degrees of reactivity with the immunodominant peptide amino acid 76-91. FACS | analysis using a panel of four murine mAbs recognizing defined rat TCR V0 products revealed that only 2-4% of the LS1 and LS2 S100~-specific bulk culture T cell lines expressed V08.2 on their surface (Table 3 ). The extent of Va8.5 expression was also very low, whereas V~10 usage was slightly higher (3-11%), as was usage of V016 (8-16%). The SP-D3 T cell line raised against the immunodominant peptide D3 also expressed low levels of V~8.2 (2%), V010 (4%), and V~8.5 (9%), and again a significant proportion of Va16 (14%). None of the $1 T cell lines tested expressed either V~8.2 or V~8.5, whereas V~16 usage was •50% in $1-C7, 80% in $1-D2, and 100% in $1-G9. Within the limits of the technique used these results demonstrate that unlike the T cell response to MBP, the Lewis rat T cell response to $100~ does not preferentially use TCR V~8.2.
SlOOfl-specific CD4 + T Cell Lines Induce an Autoimmune Panencephalitis with Uveoretinitis, Rather Than a Pure Encephalomyelitis.
Naive Lewis rats injected with 5 x 10 6, 107, or 2 x 107 LS1 and LS2 lymphoblasts failed to exhibit any dose-related clinical signs of EAE. All animals began to lose weight 4 d post T cell transfer and exhibited a transient loss of tail tone that lasted a further 3-4 d. After this time the animals began to recover weight (Fig. 2) . No other clinical signs of disease were noted, in particular hind limb paraparesis, paralysis, and urinary incontinence, which are the clin- Figure 1 . Epitope specificity of the SlOOB-specific T cell line, LS1. LS1 T line cells were restimulated with either native bovine S100fl, or synthetic rat S100B peptides (see Table 1 ) as described in the text. Only the overlapping COOH-terminal peptides amino acids 71-85 and amino acids 76-91 induced a significant proliferative response of the LS1 T cell line in vitro locating the immunodominant T cell epitope(s) to this domain of the molecule. No other peptides were found to initiate a significant proliferative response in either this, or any other of the T cell lines tested.
ical hallmarks of MBP-induced EAE, were absent. Similar losses of weight and tail tone were also observed in animals injected with 107 T cell blasts obtained from the S100fl-specific T cell lines SP-D3, S1-D1, and $1-D2. The adoptive transfer of 107 $1-G7 or $1-G9 T call blasts, which respond poorly if at all to the peptide D3 (Table 2) failed to induce any clinical changes in naive recipients. Controls injected with the same doses of PPD-specific T cell blasts showed no loss of weight, or tail tone, whereas Lewis rats injected with comparable numbers of MBP-specific T line cells developed severe clinical signs of acute EAE by day 4 (Fig. 2) . Rats were perfused 6 d after T cell transfer and the CNS (brain, spinal cord, optic nerve), peripheral nervous system (PNS) (nerve roots, sciatic nerve, trigeminal nerve), eyes, heart, lungs, tongue, thymus, kidney, spleen, bowel, adrenal glands, and salivary glands removed for histopathology.
Surprisingly, despite the absence of obvious signs of CNS disease this analysis revealed that, with one exception (T cell line $1-G9), all the S100B-specific T cell lines induced a severe inflammatory response in the CNS (Fig. 3, a, c, d , and J). Inflammatory infiltrates were also seen in the peripheral nerve roots in 60% of animals, but only very rarely in the sciatic nerve. In contrast, uveitis was very common, occurring in 49 of the 60 animals examined and was in some cases associated with scleritis, iridocyclitis, and periphlebitis retinae (Fig. 3, g, h, and i) . Uveitis was not observed in any animal with MBP-induced EAE. No inflammatory responses were seen in any other of the tissues examined.
The intensity of the inflammatory response induced in the CNS by the S100~-spedfic T cell lines was qualitatively similar to that seen in animals with severe (grade 2+), EAE induced by a MBP-specific T cell line (Figure 3, a and b) . However, unlike MBP-induced disease, in which the inflammatory lesions are most prominent in the spinal cord and rare in brain, S100~-specific T cell lines induced an inflammatory response throughout the CNS, in which involvement of both brain and spinal cord was common ( Fig. 3; Table 6 ). The difference between the two models was most marked in the cortex 823
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and mesencephalon, both of which are strongly involved in the S1003-specific T cell-mediated disease (Table 6 ). This S1003-specific T cell-mediated inflammatory disease of the CNS thus qualifies as an experimental autoimmune panencephalitis (EAP).
The Clinical Course and Histopathology of SlOOp-specific T Cell-mediated CNS Inflammation Can Be Modulated by the
Cotransfer of MOG-specific Antibody. In view of the extensive inflammation seen in animals receiving S100/5-specific T cell lines it was of interest to determine whether these clinically silent lesions could be modulated by cotransfer of the mAb 8-18C5. This mAb recognizes an epitope of the MOG exposed on the surface of the myelin membrane. Intravenous injection of this antibody in animals with MBP-mediated EAE enhances the clinical severity of the disease and induces local demyelination (41, 42) .
In the present study, intravenous injection of 4 mg of purified 8-18C5 5 d after the transfer of S100/3-specific T cells rapidly induced the classical signs of EAE, paraparesis/paralysis within 24 h (Fig. 2) . This was associated with the formation of large plaques of demyelination throughout the CNS (Fig. 3 e) . Injection of the same dose of a control mouse IgG preparation failed to induce any enhancement in either dinical status or demyelination in animals with S100B-induced CNS inflammation. The intense inflammatory response seen in the CNS of animals injected with S100~-specific T cell lines is therefore associated with an enhanced permeability of the BBB sufficient to permit the 8-18C5 mAb to enter the CNS and initiate demyelination.
The Failure of SlOOp-specific T Cells to Induce Severe Clinical Disease Is Associated with a Decreased Activation of ED1 + Macrophages in the CNS.
To investigate the cellular/physiological basis responsible for the inability of S100B-specific T cell lines to induce severe neurological disease, we examined the Lewis rats were injected intravenously with activated MBP-specific (CP1; n = 7), or S100/3-specific (LS1; n = 6) T line cells and perfused 6 d later as described in the text. The number of inflammatory infihrates/mm 2 determined in multiple tissue sections. The distribution of the lesions is strikingly different in the two models, particularly with respect to the cortex, white matter, diencephalon, and mesenencephalon that are intensively involved in the $1003 paradigm, but only exhibit moderate inflammation following the transfer of MBP-specific T cells (* significance at 98% in analysis of variance).
composition and distribution of the infiltrating inflammatory cells in the CNS. This data was compared with that obtained from studies on MBP-specific T cell-mediated EAE. Even after hematotoxylin-eosin staining it was apparent that in the S100~-specific T cell induced disease model, the perivascular lesions were very large as compared with those seen in MBP-specific T cell-induced EAE. Large numbers of cells were tightly packed into clearly delineated perivascular cuffs of inflammatory cells. Quantitative immunohistochemical analysis revealed that the absolute number of W3/13 + T cells present in the CNS on day 6 was at least 10 x greater in both the perivascular and parenchymal compartments of animals infected with the S100/3-specific T cell lines, than in MBP-induced EAE (Table 7) .
However, in contrast to the numbers of T cells found within the CNS, the expression of ED1 as a marker for lysosomal activation in macrophages was lower in rats with S100B-induced CNS inflammation. ED1 § cells are the major component of the classical EAE lesion (Table 7) , where they account for up to 80% of the infiltrating inflammatory cells, both in the perivascular space and parenchyma. This is not the case in S100B-specific T cell mediated CNS inflammation. Although the absolute number of ED1 § cells present in the CNS is approximately equal in both MBP-and S100~-specific paradigms, the proportion of this cell type entering the parenchyma is low (Table 7) . Moreover, the intensity of staining with the ED1 mAb appeared weaker in the $100~ paradigm, suggesting that these cells are poorly activated in this model. To ensure that this observation was not a staining artifact, macrophage infiltration was also evaluated using additional markers for rat macrophage populations on fresh frozen sections. The macrophage-specific mAbs ED3 and TRPM3 also demonstrated that in S100/~-mediated EAP, the number of activated macrophages present in the perivascular cuffs and parenchymal infiltrates was lower than that seen in MBP-mediated EAE. In contrast, the mAb ED2, which stains a population of resident perivascular cells in the CNS, was found to identify a similar number of cells in both MBPand S100~/-mediated diseases. Similarly, no difference in the phenotype of ramified microglia in the parenchyma was found between the two experimental models.
Astrocyte Interactions with SIOOff-specific T Cell Lines In Vitra
The cytotoxicity of several pathogenic CD4 + S100/3-specific T cell lines was assessed in vitro using syngeneic astrocytes as targets in a chromium release assay. The lewis rat MBP-specific T cell line Z85 (40) and PPD-specific T cell line LP-PPD1 (37) were used as positive and negative controls for T cell mediated cytotoxicity. In agreement with previous studies the Z85 T cell line effectively lysed IFNinduced, Ia + astrocytes in the presence of its specific antigen, MBP (40) . In striking contrast, the S1008-specific T cell lines LS1, S1-D2 and SP-D3, which induce an inflammatory response in the CNS in vivo, are completely unable to lyse Ia § astrocytes in vitro in the presence of S100B (Table 8) . Thus, unlike classic encephalitogenic MBP-specific T cells (40) , pathogenic CD4 + S100~-specific T cell lines are not cytotoxic. Moreover, although the astrocytes used in these studies were $100~ § we were unable to demonstrate the presentation of autologous $100~/by astrocytes to syngeneic T cell lines in either proliferation or cytotoxicity assays.
Discussion
This study demonstrates that in the Lewis rat, autoimmune T cells specific for an astrocyte-derived autoantigen, S100B, adoptively transfer an unusual type of inflammatory CNS disease, which can be best described as EAP. Clinical disease and histopathology in this new model of tissue specific autoimmunity differ dramatically from that seen in "classical" MBP-induced EAE, and in some respects may resemble more closely the human disease MS.
In their basic characteristics, autoaggressive $100~/-and MBP-specific T cell lines are indistinguishable; both express the CD4+CD8 -membrane phenotype and use the TCRol/~; their antigen specific responses are MHC class II (RT1.B 1) restricted, and, in addition, both MBP-and S100B-specific T cell lines are Thl-like, synthesizing IL-2 and IFN-3' upon activation. For practical reasons, the S100B-specific T cell lines were selected for reactivity against bovine $100~ protein. Epitope mapping using synthetic peptides representing rat $100~ sequences proved that most of these T cell lines are truly self-reactive. This was most dearly seen in the T cell lines LS1 and LS2 derived from the bulk lymph node cell cultures, in which the proliferative response to the COOHterminal rat $100~ peptide, amino acids 76-91, was virtually equivalent to that obtained with the native bovine protein.
This epitope appears to be immunodominant in the bulkderived S100B-specific T cell lines and its pathogenicity was confirmed using a T cell line generated using a synthetic rat $100~76-91 peptide. In contrast to the MBP-specific T cell response, recognition of this immunodominant $1003 epitope was not however found to be associated with preferential usage of the TCR V~8.2 gene.
Adoptive transfer experiments established that this S100~-specific T cell response is highly pathogenic. However the disease induced by S100~-speeific T cell lines differs radically from that produced by MBP-specific T cells. Despite the intense inflammatory response in the CNS, clinical signs of neurological dysfunction were minimal. Moreover, the histo- pathology of S1003-spedfic T ceU-mediated EAE differs from the MBP-mediated model with respect to the cellular composition and tissue distribution of the inflammatory infiltrates. The inflammatory infiltrates in the CNS of rats injected with S100/3-specific T ceils were composed predominantly of T cells and contained approximately 10 times the number of infiltrating T cells seen in rats injected with an equivalent number of encephalitogenic MBP-specific T cells. In contrast, activated macrophages that are the dominant cell population in MBP-induced EAE lesions (43, 44) , accounted for only a minority of the infiltrating inflammatory cells in the S1003 paradigm.
The distribution of lesions in S100~-induced disease correlated roughly with the pattern of S1003 expression within the CNS and adjacent tissues. S1003 is present in astrocytes (in both the grey and white matter) in the CNS, in Schwann ceils in the PNS and in astrocytes and Miiller ceils in the eye (45) . Thus inflammatory infiltrates were noted throughout the CNS, including cortex, telencephalon, optic nerve, and cerebellum, as well as in the PNS and eye. This is in contrast to MBP-induced EAE in which the target autoantigen is only expressed by myelinating oligodendrocytes and Schwann cells and is not expressed in the uvea or retina as these tissues are not myelinated. Uveitis is therefore not seen in the MBPinduced model of EAE. MBP and S100/3 are, however, both expressed at high concentrations along the whole length of the spinal cord, as well as in the brain. It is therefore striking that whereas in MBP-induced EAE the lesions tend to be concentrated in the caudal segments of the spinal cord (46) , in S100/~-induced disease lesions are found throughout the CNS. The adoptive transfer of S100/~-specific T line cells therefore induce an EAP that is clearly distinguishable from the classical model of MBP-induced encephalomyelitis. This observation indicates that as yet unspecified factors modulate the ability of local APCs within the brain to process and present specific autoantigens within different regions of the CNS.
The ability of S100~3-specific T cells to induce an intense inflammatory response throughout the CNS is in marked contrast to their inability to induce severe neurological dysfunction. Considering the number and the localization of the inflammatory infiltrates, one would expect the animals to develop severe, if not lethal disease. There are at least two observations that could account for this discrepancy, and these are by no means mutually exclusive.
First, it should be remembered that most, if not all, encephalitogenic MBP-specific T cells exhibit antigen specific, class II MHC-restricted cytotoxicity in several different species (40, 47, 48) . It was postulated that target cell lysis, as measured in vitro, reflected the encephalitogenic potential of MBP-specific T cells in vivo. However, in contrast to MBPspecific T cells, none of the S100B-specific T cell lines tested were cytotoxic.
Second, it is well established that macrophages are critically involved in mediating clinical disease in MBP-mediated EAE. Depletion of the macrophage population has been shown to migrate clinical EAE (49, 50) despite the continued presence of inflammatory infiltrates in the CNS (50) . Interest-
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ingly, in EAP there is a reduced migration of activated (ED1 +) macrophages from the perivascular space into the CNS parenchyma. This could account in part for the mild clinical course of EAP and can be best explained by a deficit in the production of cytokines known to recruit individual mononuclear blood cells into areas of inflammation. Although cytokine assays for IL-2, TNF-oe/I3 and IFN-3, did not reveal gross differences between MBP and S10013-spedfic T cells (both behaved like Thl cells), there could be dissimilarities in the release of other chemotactic cytokines such as IL-8, MIP-1, CP-1, MCP-1, etc., in vivo. These factors are under investigation at present, although at present we cannot yet establish any direct link between the absence of S100B-specific T cell-mediated cytotoxicity and the composition of the inflammatory infiltrates. This new model of autoimmune-mediated CNS inflammation has direct relevance for our understanding of the immunopathogenesis of MS and other putative autoimmune inflammatory diseases of the nervous system. Although the human retina and uvea are not myelinated (51) , these tissues are involved in some patients with MS (51, 52, reviewed in 26), periphlebitis retinae occurring in 10-40% of patients (51, 26) and in another series of cases inflammation of the urea was seen in 5-27% of the patients studied (53) (54) (55) . Moreover, pathological abnormalities in the retinal endothelium of patients with acute isolated optic neuritis are also a significant additional risk factor for MS (56) . The absence of myelin in these tissues is difficult to reconcile with the concept that MS is exclusively caused by a myelin-specific autoimmune response, particularly as inflammation of these tissues was not seen in MBP-specific T cell-mediated EAE. Our results raise the possibility the primary autoantigen in some cases of MS may not be solely derived from myelin, but that other cellular compartments in the CNS may also provide appropriate autoantigenic targets. This notion that a nonmyelin autoantigen could have a role in a demyelinating inflammatory disease may at first seem bizarre. However, nuclear magnetic imaging studies in MS and EAE also indicate that the primary event in disease pathogenesis is an increased permeability of the BBB (57, 58) and that this is triggered by a T cell-mediated response in the CNS (59) . We have now demonstrated that this inflammatory response need not necessarily be myelin specific, although an additional myelin-specific effector mechanism, such as MOG-specific autoantibody response is required to produce a demyelinating white matter pathology similar to that seen in MS. The immunopathogenesis of the MS lesion, at least in some cases could be a consequence of multiple autoimmune responses to a variety of CNS autoantigens.
Finally we predict that many additional myelin and nonmyelin brain determinants will be identified as potential encephalitogens. This concept is crucial for the future development of novel therapeutic strategies for MS, since once established disease may be driven by a polyclonal T cell-mediated autoimmune response against different CNS antigens. Such responses may also play an important role in the pathogenesis of other inflammatory brain diseases, including the inflammatory response that is often associated with neoplasia.
